SG158916A1 - Nitrooxy derivatives op glucocorticoids - Google Patents

Nitrooxy derivatives op glucocorticoids

Info

Publication number
SG158916A1
SG158916A1 SG201000520-5A SG2010005205A SG158916A1 SG 158916 A1 SG158916 A1 SG 158916A1 SG 2010005205 A SG2010005205 A SG 2010005205A SG 158916 A1 SG158916 A1 SG 158916A1
Authority
SG
Singapore
Prior art keywords
glucocorticoids
nitrooxy derivatives
new steroids
nitrooxyderivatives
nitrooxy
Prior art date
Application number
SG201000520-5A
Other languages
English (en)
Inventor
Benedini Francesca
Ongini Ennio
Guglietta Antonio
Palop Daniel
Princep Marta
Original Assignee
Nicox Sa
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37450883&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG158916(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nicox Sa, Ferrer Int filed Critical Nicox Sa
Publication of SG158916A1 publication Critical patent/SG158916A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
SG201000520-5A 2005-09-02 2006-08-04 Nitrooxy derivatives op glucocorticoids SG158916A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05019155 2005-09-02

Publications (1)

Publication Number Publication Date
SG158916A1 true SG158916A1 (en) 2010-02-26

Family

ID=37450883

Family Applications (1)

Application Number Title Priority Date Filing Date
SG201000520-5A SG158916A1 (en) 2005-09-02 2006-08-04 Nitrooxy derivatives op glucocorticoids

Country Status (19)

Country Link
US (5) US20080221073A1 (es)
EP (1) EP1940863B1 (es)
JP (1) JP5216589B2 (es)
KR (1) KR20080039442A (es)
CN (2) CN102134269A (es)
AR (1) AR056868A1 (es)
AU (1) AU2006286838C1 (es)
BR (1) BRPI0614967A2 (es)
CA (1) CA2621117A1 (es)
ES (1) ES2393363T3 (es)
IL (2) IL189337A0 (es)
NO (1) NO20081614L (es)
NZ (1) NZ566128A (es)
RU (1) RU2415864C2 (es)
SG (1) SG158916A1 (es)
TW (1) TW200801031A (es)
UY (1) UY29779A1 (es)
WO (1) WO2007025632A2 (es)
ZA (1) ZA200801789B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8802726B2 (en) 2006-02-03 2014-08-12 Nicox S.A. Use of nitrooxyderivative of drug for the treatment of muscular dystrophies
EP2109617A1 (en) * 2007-02-05 2009-10-21 Nicox S.A. Nitric oxide releasing steroids
EP1964550A1 (en) * 2007-03-01 2008-09-03 NicOx S.A. Glucocorticoid-nitrooxyderivative compositions
ES2324007A1 (es) * 2007-10-25 2009-07-28 Ferrer Internacional, S.A. Una forma amorfa de un compuesto antiinflamatorio.
BRPI0916702A2 (pt) * 2008-07-31 2015-11-10 Nicox Sa composto, uso de um composto, e, composição farmacêutica.
CN102186874A (zh) * 2008-08-05 2011-09-14 尼科克斯公司 新的释放no的类固醇衍生物
EP2321333A1 (en) 2008-08-05 2011-05-18 Nicox S.A. New no-releasing steroids for the treatment of retina and macula lutea diseases
US8062653B2 (en) * 2009-02-18 2011-11-22 Bezwada Biomedical, Llc Controlled release of nitric oxide and drugs from functionalized macromers and oligomers
WO2010096320A2 (en) * 2009-02-18 2010-08-26 Bezwada Biomedical, Llc Controlled release of nitric oxide and drugs from functionalized macromers and oligomers
US9022788B2 (en) * 2009-10-17 2015-05-05 Gregory John Stahler System and method for cardiac defibrillation response simulation in health training mannequin
ES2362894B1 (es) 2009-11-16 2012-05-21 Ferrer Internacional S.A. Procedimiento de preparación del �?cido 4-nitro-oxi-metil-benzoico.
ES2359708B1 (es) 2009-11-16 2012-03-30 Ferrer Internacional S.A. Procedimiento de preparación de la (11beta,16alfa)-9-fluoro-11-hidroxi-16,17-[1-metil-etilidenebis(oxi)]-21-[1-oxo-[4-(nitrooximetil)benzoxi]]preña-1,4-dien-3,20-diona.
CN110382033B (zh) * 2016-10-14 2022-04-15 范安德尔研究所 用于设计高效力糖皮质激素的结构与机制
US20230131943A1 (en) 2020-03-24 2023-04-27 Burnet Micheal W Anti-infective and anti-viral compounds and compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335121A (en) 1980-02-15 1982-06-15 Glaxo Group Limited Androstane carbothioates
GR1001529B (el) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
US5824669A (en) * 1996-03-22 1998-10-20 Nitromed, Inc. Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
US5837698A (en) * 1996-05-02 1998-11-17 G. D. Searle & Co. Steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs
US5985862A (en) * 1996-05-02 1999-11-16 G.D. Searle & Co. Pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs
IT1285770B1 (it) * 1996-10-04 1998-06-18 Nicox Sa Composti corticoidei
IT1311922B1 (it) 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
ITMI20020148A1 (it) * 2002-01-29 2003-07-29 Nicox Sa Nuovi corticosteroidi
EP1336602A1 (en) * 2002-02-13 2003-08-20 Giovanni Scaramuzzino Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases

Also Published As

Publication number Publication date
TW200801031A (en) 2008-01-01
ZA200801789B (en) 2008-12-31
US20090264393A1 (en) 2009-10-22
KR20080039442A (ko) 2008-05-07
RU2008111076A (ru) 2009-10-10
ES2393363T3 (es) 2012-12-20
AU2006286838A1 (en) 2007-03-08
WO2007025632A3 (en) 2007-04-19
NO20081614L (no) 2008-05-28
US20110294769A1 (en) 2011-12-01
CA2621117A1 (en) 2007-03-08
US20080221073A1 (en) 2008-09-11
US20090258849A1 (en) 2009-10-15
JP2009506994A (ja) 2009-02-19
JP5216589B2 (ja) 2013-06-19
CN101300265A (zh) 2008-11-05
WO2007025632A2 (en) 2007-03-08
AU2006286838C1 (en) 2013-05-02
RU2415864C2 (ru) 2011-04-10
IL216516A0 (en) 2011-12-29
CN102134269A (zh) 2011-07-27
BRPI0614967A2 (pt) 2013-01-01
UY29779A1 (es) 2006-12-29
US20090264394A1 (en) 2009-10-22
AR056868A1 (es) 2007-10-31
EP1940863A2 (en) 2008-07-09
IL189337A0 (en) 2008-06-05
NZ566128A (en) 2011-03-31
EP1940863B1 (en) 2012-09-05
AU2006286838B2 (en) 2012-03-29

Similar Documents

Publication Publication Date Title
SG158916A1 (en) Nitrooxy derivatives op glucocorticoids
LTC1620113I2 (lt) Ivermektino topinė kompozicija, skirta dermatologinių susirgimų gydymui
EP2358378A4 (en) TOPICAL FORMULATION FOR THE TREATMENT OF INFLAMMATORY DISEASE, SKIN AND SLAUGHTER DISEASES AND SIMILAR DISEASES
CY1118065T1 (el) Καινοτομες αμινογλυκοσιδες και χρησεις αυτων στη θεραπεια γενετικων διαταραχων
TW200716646A (en) (S)-N-methylnaltrexone
EP1727530A4 (en) TOPICAL FORMULATIONS FOR THE TREATMENT OF DERMATOLOGICAL CONDITIONS
HK1139930A1 (en) Cyclopamine lactam analogs and methods of use thereof
NO20075660L (no) Blanding for behandling av inflammatoriske sykdommer
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
TW200611695A (en) Pyrrolopyridine derivatives
CO5660287A2 (es) Derivados de tetrahidrocarbazol y su uso farmaceutico
WO2009009417A3 (en) Pharmaceutical compositions and methods of preventing, treating, or inhibiting inflammatory diseases, disorders, or conditions of the skin, and diseases, disorders, or conditions associated with collagen depletion
WO2009071689A3 (de) 5-halogen-substituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen
DE50312034D1 (de) Liposomale glucocorticoide
IL190841A0 (en) Pharmaceutical compositions and diagnostic methods for inflammatory skin diseases, disorders or conditions
CR6824A (es) Derivados de arilmetilamina para uso como inhibidores de triptasa
WO2007022305A3 (en) 2-aminoimidazopyridines for treating neurodegenerative diseases
UA86399C2 (ru) Применение 2,5 дигидроксибензолсульфоновой кислоты для изготовления лекарства, которые применяют для лечения болезней, зависимых от ангиогенеза
WO2007048097A3 (en) Anbrosteeone derivatives and method of use thereof
ZA201000581B (en) 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazepine-7-carboxamide derivatives,preparation and therapeutic use thereof
WO2007017146A3 (en) Use of collismycin and derivatives thereof as oxidative stress inhibitors
DK1487859T3 (da) Fremstillingsmetoder til at fremstille Eplerenon
TW200738611A (en) 9-Chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments
WO2007053915A3 (en) Naringenin derivatives with selectivity on ers
ATE505477T1 (de) Amorphe form von (11beta,16alpha)-9-fluoro-11-